FDA has recently approved two groundbreaking treatments, Casgevy and Lyfgenia, which characterize the cell-based gene therapies for treating sickle cell diseases in individuals 12 years and older. Casegevy was the first approved treatment to use...
Point-of-care ultrasound (POCUS) refers to the practice of trained medical professionals using ultrasound to diagnose problems wherever a patient is being treated, whether that's in a modern hospital, an ambulance, or a remote medical facility. Po...
The Indian pharmaceutical market size was valued at USD 48.4 Billion in 2022. When we look ahead, the market is in the growth trajectory phase as it anticipates reaching USD 102.7 Billion by 2028, showcasing a growth rate of 13.01% during 2023-202...
Neonatal care has come a long way in recent years, with advancements in medical technology and innovative approaches transforming the landscape of newborn healthcare. In India, where the rate of preterm births and neonatal mortality has been a lon...
The emerging trends of CDMOs reflect the country's growing prominence as a preferred outsourcing destination for drug development and manufacturing activities The growth and evolution of the CDMO industry have been driven by factors such as cost a...
Beneath the superficial veneer of device usability analysis lies a complex and multi-dimensional paradigm. It necessitates the use of ethnographic methodologies, immersive contextual analysis, and a granular understanding of user behavior, encompa...
Establishing a strong brand identity is critical for success in the intensely competitive pharmaceutical market. A captivating brand identity is more than simply a logo and a tagline; it represents the company's values, goals, and purpose.
The market for prefilled syringes was estimated to be worth USD 7.22 billion in 2022 and is anticipated to grow to USD 7.91 billion in 2023. By 2030, the market is anticipated to reach USD 16.32 billion, growing at a CAGR of 10.9%. Prefilled...
The agreement was launched by AliveCor India Pvt. Ltd., the leading inventor in FDA-cleared personal electrocardiogram (ECG) technology, and Vieroots Wellness Solutions Pvt Ltd, a health-tech start-up focused to giving personalised solutions to...
Zion Pharma Limited, a Chinese biotechnology firm specialising in the creation of substances that may penetrate the brain, revealed today that Roche has purchased the worldwide rights to Zion's principal programme, ZN-A-1041. ZN-A-1041 is a Human...
, CDSCO.jpg)